Trailing-twelve-month (TTM) revenue is $228.56 Million with a year-over-year growth of +9.41%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q1 FY2026Period ended 2025-08-30 | $54,607,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-09 |
| Q2 FY2026Period ended 2025-11-29 | $52,288,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-01-08 |
| Q3 FY2026Period ended 2026-02-28 | $55,472,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-09 |
| Q4 FY2026Period ended 2026-05-30 | $66,197,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-03 |
| TTM revenue | $228,564,000 |
Current P/S: $278,596,382 market capitalization ÷ $228,564,000 TTM revenue = 1.22x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:00.000Z. Latest revenue period ended 2026-05-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q4 FY2026 (2026-05-30): $66.20M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T22:43:01.446Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-05-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-05-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-05-29 · USD | FY20222022-05-28 · USD | FY20232023-05-27 · USD | FY20242024-06-01 · USD | FY20252025-05-31 · USD | FY20262026-05-30 · USD |
|---|---|---|---|---|---|---|
| Canvys | $29M | $35M | $39M | $32M | $33M | $37M |
| Healthcare Segment | $10M | $11M | $11M | $12M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-05-29 · USD | FY20222022-05-28 · USD | FY20232023-05-27 · USD | FY20242024-06-01 · USD | FY20252025-05-31 · USD | FY20262026-05-30 · USD |
|---|---|---|---|---|---|---|
| Asia Pacific | $41M | $49M | $60M | $45M | $43M | $58M |
| Europe | $53M | $64M | $62M | $61M |
$228.56M
$228.56 Million
+9.41%
vs. $208.91M a year ago (TTM)
+6.55%
5 Year compound annual growth rate
1 Year
+9.41%
3 Year
(4.49%)
5 Year
+6.55%
10 Year
+5.09%
15 Year
(2.98%)
20 Year
(4.76%)
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $228.56M | +$19.66M | +9.41% |
| 2025 | $208.91M | +$12.45M | +6.34% |
| 2024 | $196.46M | ($66.20M) | (25.20%) |
| 2023 | $262.66M | +$38.04M | +16.93% |
| 2022 | $224.62M | +$47.68M | +26.95% |
| 2021 |
TTM Growth
+9.41%
3-Year CAGR
(4.49%)
5-Year CAGR
+6.55%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T22:43:01.446Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $9M |
| N/A |
| Power And Microwave Technologies Group | $137M | $178M | $164M | $129M | $138M | $160M |
|---|
| $66M |
| Latin America | $10M | $12M | $29M | $11M | $8M | $7M |
|---|
| North America | $74M | $99M | $112M | $77M | $91M | $98M |
|---|
| Unallocated Other | $273,000 | -$16,000 | -$54,000 | $2M | $1M | N/A |
|---|
| $176.94M |
| +$21.04M |
| +13.50% |
| 2020 | $155.90M | ($10.75M) | (6.45%) |
| 2019 | $166.65M | +$3.44M | +2.11% |
| 2018 | $163.21M | +$26.34M | +19.24% |
| 2017 | $136.87M | ($5.14M) | (3.62%) |
